BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include MyoAAV Plasmids through a License Agreement from the Broad Institute of MIT and Harvard

  August 6, 2024

   · 

  3 min read
• Press Releases

  Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to September 3, 2024

  August 6, 2024

   · 

  9 min read
• Press Releases

  Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Malaysia

  August 6, 2024

   · 

  5 min read
• Press Releases

  Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone

  August 6, 2024

   · 

  5 min read
• Press Releases

  First Patient Enrolled in the US Phase 2 Combination Therapy of Akeso’s Ligufalimab with Azacitidine for Myelodysplastic Syndrome

  August 6, 2024

   · 

  4 min read
• Press Releases

  MolecuLight’s Profound Impact on Wound Healing Highlighted in Breaking Clinical Research

  August 6, 2024

   · 

  3 min read
• Press Releases

  ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

  August 6, 2024

   · 

  25 min read
• Press Releases

  Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024

  August 6, 2024

   · 

  1 min read
• Press Releases

  Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update

  August 6, 2024

   · 

  22 min read
• Press Releases

  Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

  August 6, 2024

   · 

  10 min read